Connect with us
Hospitals sued in Maine to freeze a 340B rebate pilot that would make them pay wholesale first on 21 listed drugs.
Kenya's first Ebola death arrived on a commercial flight from Kampala. Bundibugyo has no licensed vaccine, and 108 contacts remain in quarantine.
A 1995 packaging threshold would cover chemicals added on purpose to food, using cancer-era math that hormone-disrupting doses can already beat.
The United States has confirmed 4,080 measles cases in 2026, only 18 of them in visitors, after kindergarten MMR coverage fell to 92.4%.
Kenya’s first Bundibugyo Ebola death is an imported DRC case. Licensed vaccines miss this species, and 122 contacts are now under watch.
Medicare Advantage premiums fall to $12 in 2027, but 70 percent of members face a higher yearly cap as insurers cut dental dollars and open networks.
A Danish campus panel cleared a 14,000-infant hepatitis B trial in Guinea-Bissau after the US dropped universal birth doses and Bissau postponed its 2028 rollout.
Cancer Research UK puts England’s 85% 62-day cancer treatment rate at 77.8% by 2029, with most long waits still sitting in the test queue.
PhRMA sued to block GLOBE, a Medicare Part B price test rebuilt after courts halted a 2020 most-favored-nation rule.
Early-onset cancer is climbing in England, the US and the Netherlands, fastest in people still too young for NHS bowel and breast screening.
